• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种剂量的低分子量肝素PK 10169预防103例股骨颈骨折治疗期间血栓栓塞事件的对比研究

[Comparative study of 2 dosages of low molecular weight heparin, PK 10169, in the prevention of thromboembolic incidents during treatment of 103 femur neck fractures].

作者信息

Barsotti J, Dabo B, Andreu J, Favard L, Rosset P, Leroy J, Delahousse R, Alison D

机构信息

Service de Chirurgie générale et Traumatologie, Hôpital Trousseau, Chambray-les-Tours.

出版信息

J Mal Vasc. 1987;12 Suppl B:96-8.

PMID:2834501
Abstract

Results of this study in the elderly with fractures of femoral neck, in whom their exists an enhanced thrombogenic risk, showed that the dose of 40 mg per 24 hours as one or two divided injections of enoxaparine was as effective as adapted subcutaneous doses of calcium heparinate. It was also less iatrogenic and easier to manage (biological assays were of little use apart from platelet counts). Clinical evidence of pulmonary embolism, or mortality, were not observed in this series of 103 patients.

摘要

本研究针对存在血栓形成风险增加的老年股骨颈骨折患者,结果显示,每24小时40毫克依诺肝素分一次或两次注射的剂量,与调整后的皮下注射肝素钙剂量效果相同。而且它的医源性损伤更小,更易于管理(除血小板计数外,生物学检测作用不大)。在这103例患者中,未观察到肺栓塞的临床证据或死亡情况。

相似文献

1
[Comparative study of 2 dosages of low molecular weight heparin, PK 10169, in the prevention of thromboembolic incidents during treatment of 103 femur neck fractures].两种剂量的低分子量肝素PK 10169预防103例股骨颈骨折治疗期间血栓栓塞事件的对比研究
J Mal Vasc. 1987;12 Suppl B:96-8.
2
[Prevention of thromboembolism using low molecular weight heparin and hemodilution in traumatologic geriatric surgery of the femur neck].[低分子量肝素联合血液稀释在老年股骨颈创伤外科手术中预防血栓栓塞的应用]
Cah Anesthesiol. 1990 Nov;38(5):319-24.
3
[Non controlled prospective study of the efficacy and tolerance of a low molecular weight heparin].低分子量肝素疗效与耐受性的非对照前瞻性研究
J Mal Vasc. 1991;16(4):367-71.
4
[Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients].[低分子量肝素在门诊手术及未手术的外科和骨科患者中预防血栓栓塞的应用]
Zentralbl Chir. 1998;123(11):1284-7.
5
[Prevention of thromboembolism in hip fracture: unfractionated heparin versus low molecular weight heparin ( a prospective, randomized study)].
Z Unfallchir Versicherungsmed. 1993;86(3):184-8.
6
A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.一项关于新型第二代低分子肝素(苄丙酮香豆素钠)和普通肝素预防术后静脉血栓栓塞的双盲随机对照试验。苄丙酮香豆素钠评估组。
Thromb Haemost. 2000 Apr;83(4):523-9.
7
[Prevention of thromboembolism in surgery of fractures of the upper end of the femur].
Sb Lek. 2002;103(2):203-12.
8
[Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].[大型骨科手术并发症的评估:吲哚布芬、钙肝素和低分子肝素的比较]
Minerva Anestesiol. 1996 Mar;62(3):93-100.
9
[Locoregional anesthesia combined with a low molecular weight heparin in the prevention of thromboembolic disease].[局部区域麻醉联合低分子量肝素预防血栓栓塞性疾病]
Cah Anesthesiol. 1992;40(8):603-7.
10
[Prevention of venous thromboemboli with low doses of heparin in patients with proximal femur fractures].[低剂量肝素预防股骨近端骨折患者静脉血栓栓塞]
Zentralbl Chir. 1980;105(7):460-4.